adenine has been researched along with Glomerulonephritis, Membranous in 4 studies
Glomerulonephritis, Membranous: A type of glomerulonephritis that is characterized by the accumulation of immune deposits (COMPLEMENT MEMBRANE ATTACK COMPLEX) on the outer aspect of the GLOMERULAR BASEMENT MEMBRANE. It progresses from subepithelial dense deposits, to basement membrane reaction and eventual thickening of the basement membrane.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The use of lamivudine and tenofovir resulted in arrest of proteinuria and stabilisation of renal function." | 7.77 | Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir. ( Das, P; Ford, M; Holt, S; Kingdon, E; Vivek, V, 2011) |
| " The use of lamivudine and tenofovir resulted in arrest of proteinuria and stabilisation of renal function." | 3.77 | Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir. ( Das, P; Ford, M; Holt, S; Kingdon, E; Vivek, V, 2011) |
| "We report on how adefovir-induced membranous nephropathy related to hepatitis B was caused by lamivudine-resistant virus after a liver transplant due to Byler's disease." | 1.38 | A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler's disease. ( Ebata, S; Hashimoto, S; Ishikawa, Y; Ito, M; Koike, T; Maoka, T; Mochizuki, T; Suzuki, A, 2012) |
| "Lamivudine treatment improves renal outcome in patients with hepatitis B virus-associated MN (HBV-MN), but prolonged use leads to the emergence of lamivudine-resistant variants." | 1.38 | Experience of anti-viral therapy in hepatitis B-associated membranous nephropathy, including Lamivudine-resistant strains. ( Choi, BS; Choi, SR; Chung, BH; Hong, YA; Kim, YS; Park, CW; Park, HS; Sun, IO; Yang, CW, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Numata, A | 1 |
| Akimoto, T | 1 |
| Toshima, M | 1 |
| Iwazu, Y | 1 |
| Otani, N | 1 |
| Miki, T | 1 |
| Sugase, T | 1 |
| Saito, O | 1 |
| Hamano, Y | 1 |
| Takemoto, F | 1 |
| Ueda, Y | 1 |
| Muto, S | 1 |
| Kusano, E | 1 |
| Das, P | 1 |
| Vivek, V | 1 |
| Ford, M | 1 |
| Kingdon, E | 1 |
| Holt, S | 1 |
| Ebata, S | 1 |
| Hashimoto, S | 1 |
| Suzuki, A | 1 |
| Ito, M | 1 |
| Maoka, T | 1 |
| Ishikawa, Y | 1 |
| Mochizuki, T | 1 |
| Koike, T | 1 |
| Sun, IO | 1 |
| Hong, YA | 1 |
| Park, HS | 1 |
| Choi, SR | 1 |
| Chung, BH | 1 |
| Park, CW | 1 |
| Yang, CW | 1 |
| Kim, YS | 1 |
| Choi, BS | 1 |
4 other studies available for adenine and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Membranous nephropathy in an HIV-positive patient complicated with hepatitis B virus infection.
Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Deoxycytidine; Emtricitabine | 2011 |
Hepatitis B virus related membranous glomerulonephritis and proteinuria treated with lamivudine and tenofovir.
Topics: Adenine; Glomerulonephritis, Membranous; Hepatitis B, Chronic; Humans; Lamivudine; Male; Organophosp | 2011 |
A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler's disease.
Topics: Adenine; Adolescent; Adult; Child, Preschool; Cholestasis, Intrahepatic; Drug Resistance, Viral; Fem | 2012 |
Experience of anti-viral therapy in hepatitis B-associated membranous nephropathy, including Lamivudine-resistant strains.
Topics: Adenine; Adult; Antiviral Agents; Arabinofuranosyluracil; Drug Resistance, Viral; Female; Glomerulon | 2012 |